普洛药业(000739) - 2018 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2018 was CNY 1,445,922,686.96, representing a 9.24% increase compared to CNY 1,323,631,271.08 in the same period last year[8] - Net profit attributable to shareholders was CNY 67,162,129.52, a 38.33% increase from CNY 48,552,175.33 year-on-year[8] - The net profit after deducting non-recurring gains and losses was CNY 63,615,406.15, up 32.67% from CNY 47,950,190.91 in the previous year[8] - Total profit rose by 32.55% to ¥83,069,250.05, driven by increased sales volume in the formulation business and higher gross margins from raw material intermediates[15] - Net profit increased by 38.33% to ¥67,162,129.52, attributed to the same factors as total profit[15] Cash Flow and Assets - The net cash flow from operating activities surged to CNY 202,134,293.38, a significant increase of 8,582.21% compared to CNY 2,328,144.47 in the same period last year[8] - Total assets at the end of the reporting period were CNY 5,844,572,564.61, a 2.70% increase from CNY 5,691,123,928.46 at the end of the previous year[8] - Net assets attributable to shareholders increased to CNY 3,116,803,858.66, up 2.19% from CNY 3,049,994,608.50 at the end of the last year[8] - Cash and cash equivalents decreased by 57.70% to ¥74,317,679.47, largely due to significant loan repayments in the current period[15] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 55,788[10] Expenses and Liabilities - Sales expenses surged by 91.01% to ¥162,865,667.79, primarily due to increased business and promotional costs[15] - Financial expenses rose by 47.74% to ¥31,368,317.55, mainly due to increased foreign exchange gains and losses[15] - The company repaid debts amounting to ¥732,499,394.33, an increase of 86.80% compared to the previous period[15] Investment and Gains - Investment income surged by 763.45% to ¥1,516,253.34, reflecting increased profits from joint ventures[15] - The company reported non-recurring gains of CNY 3,546,723.37 during the reporting period[9] Compliance and Governance - The company did not report any non-compliance with external guarantees or non-operational fund occupation by major shareholders during the reporting period[16][20][21] Earnings Per Share - Basic earnings per share rose to CNY 0.0570, reflecting a 34.75% increase from CNY 0.0423 in the previous year[8] Return on Assets - The weighted average return on net assets was 2.18%, an increase of 0.32% compared to 1.86% in the previous year[8] Receivables and Prepayments - Prepayments increased by 35.20% to ¥137,389,902.37 due to higher material payments in the current period[15] - Receivables increased by 38.68% to ¥104,122,252.21 as a result of increased cash received for goods[15]